ACE2 and COVID-19: As we are still in the early stages of understanding the pathogenesis of COVID-19, more extensive research is required to validate the initial findings and also to establish whether and how an increased ACE2 expression contributes to the initiation and progression of COVID-19 in smokers and COPD patients.